India, June 24 -- The Department of Pharmaceuticals (DoP) has invited comments from stakeholders on proposed amendments to the Global Tender Enquiry (GTE) Exemption List for Medical Devices.
The move follows a public notice issued in February 2026 seeking feedback on the existing exemption list. Based on the responses received, various stakeholders have proposed additions, deletions, and modifications to the list.
The Department has requested domestic manufacturers, importers, industry associations, procurement agencies, and healthcare institutions to submit their comments and supporting information by July 15, 2026.
The consultation aims to review and update the GTE Exemption List to better align with industry requirements and the evolv...